Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is the primary cause of death among pulmonary cancer patients. Upregulation of CD80 may interact with cytotoxic T lymphocyte antigen 4 (CTLA4) to promote tumor progression and provide a potential target for biological antitumor therapy. However, the role of CD80 in LUAD is...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wei, He, Ziyi, Shi, Liang, Zhu, Zheng, Ma, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517904/
https://www.ncbi.nlm.nih.gov/pubmed/36892747
http://dx.doi.org/10.1007/s10528-023-10343-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517904/
https://www.ncbi.nlm.nih.gov/pubmed/36892747
http://dx.doi.org/10.1007/s10528-023-10343-7

Ejemplares similares